Drugs & Therapy Perspectives

, Volume 34, Issue 8, pp 392–401 | Cite as

Defining an ‘older’ patient in the context of therapeutic decision making: perspectives of Australian pharmacists and nurses

  • Natalia Krzyżaniak
  • Shamsher Singh
  • Beata Bajorek
Original Research Article



Our aim was to explore Australian nurses and pharmacist’s perspectives on defining an ‘older’ patient in the context of decision making around pharmacotherapy.


A qualitative study was conducted using semi-structured interviews, facilitated by a purpose-designed interview guide.


Practitioners were recruited from the primary care (i.e. registered community pharmacists, registered community nurses, general practice nurses) and tertiary care settings (i.e. referral hospitals, specialist clinics).


Non-prescribing health professionals directly involved in medication management (i.e. nurses, pharmacists) with experience in caring for older patients.


This exploratory study identified three key themes: (1) defining ‘older’ patients is difficult, given the heterogeneity of the population; (2) age is more than a number and, therefore, cannot be used alone for tailoring and managing a patient’s treatment; and (3) a contemporary definition of an ‘older’ patient needs to be integrated into guidelines for treating aged patients. Overall, Australian nurses and pharmacists shared similar perspectives about defining an ‘older’ patient, favouring holistic assessments of individual patients.


Non-prescribing health practitioners, such as nurses and pharmacists, advocate an individualised approach, rather than a number-based approach, to decision making in older patients.


Compliance with ethical standards

Conflict of interest

Natalia Krzyżaniak, Shamsher Singh and Beata Bajorek declare there are no conflicts of interest.


None to declare.


  1. 1.
    Ageing and health: fact sheet No 404. 2015. Accessed 25 Sept 2016.
  2. 2.
    Le Couteur DG, Ford GA, McLachlan AJ. Evidence, ethics and medication management in older people. J Pharm Pract Res. 2010;40(2):148–52.CrossRefGoogle Scholar
  3. 3.
    Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84.CrossRefGoogle Scholar
  4. 4.
    Gallagher S, Bennett KM, Halford JC. A comparison of acute and long-term health-care personnel’s attitudes towards older adults. Int J Nurs Pract. 2006;12(5):273–9.CrossRefGoogle Scholar
  5. 5.
    Singh S, Bajorek B. Pharmacotherapy in the ageing patient: the impact of age per se (a review). Ageing Res Rev. 2015;24:99–110.CrossRefGoogle Scholar
  6. 6.
    Gnavi R, Migliardi A, Demaria M, et al. Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy: a case of ageism and social inequalities. Eur J Public Health. 2007;17(5):492–6.CrossRefGoogle Scholar
  7. 7.
    Jacobson TA. Overcoming ‘ageism’ bias in the treatment of hypercholesterolaemia: a review of safety issues with statins in the elderly. Drug Saf. 2006;29(5):421–48.CrossRefGoogle Scholar
  8. 8.
    Singh S, Bajorek B. Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy. Pharm Pract. 2014;12(4):489.Google Scholar
  9. 9.
    Lee JK, Alshehri S, Kutbi HI, et al. Optimizing pharmacotherapy in elderly patients: the role of pharmacists. Integr Pharm Res Pract. 2015;4:101–11.CrossRefGoogle Scholar
  10. 10.
    Lu WH, Wen YW, Chen LK, et al. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study. CMAJ. 2015;187(4):E130–7.CrossRefGoogle Scholar
  11. 11.
    Obreli Neto PR, Nobili A, de Lyra DP Jr, et al. Incidence and predictors of adverse drug reactions caused by drug–drug interactions in elderly outpatients: a prospective cohort study. J Pharm Pharm Sci. 2012;15(2):332–43.CrossRefGoogle Scholar
  12. 12.
    Wang Y, Singh S, Bajorek B. Old age, high risk medication, polypharmacy: a ‘trilogy’ of risks in older patients with atrial fibrillation. Pharm Pract (Granada). 2016;14(2):706.CrossRefGoogle Scholar
  13. 13.
    Australian Institute of Health and Welfare. Older people. 2018. Accessed 20 Apr 2018.
  14. 14.
    Slack C. Biological vs chronological age: how old are you really? 2016. Accessed 20 Apr 2018.
  15. 15.
    Jia L, Zhang W, Chen X. Common methods of biological age estimation. Clin Interv Aging. 2017;12:759–72.CrossRefGoogle Scholar
  16. 16.
    Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation. 2007;115(8):949–52.CrossRefGoogle Scholar
  17. 17.
    Nakamura E, Lane MA, Roth GS, et al. Evaluating measures of hematology and blood chemistry in male rhesus monkeys as biomarkers of aging. Exp Gerontol. 1994;29(2):151–77.CrossRefGoogle Scholar
  18. 18.
    Nakamura E, Miyao K. Further evaluation of the basic nature of the human biological aging process based on a factor analysis of age-related physiological variables. J Gerontol A Biol Sci Med Sci. 2003;58(3):196–204.CrossRefGoogle Scholar
  19. 19.
    Krzyzaniak N, Singh S, Bajorek B. Physicians’ perspectives on defining an older adult patient and in making appropriate prescribing decisions. Drugs Ther Perspect. 2018;34(4):174–85.CrossRefGoogle Scholar
  20. 20.
    Somers A, Robays H, De Paepe P, et al. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging. 2013;8:703–9.CrossRefGoogle Scholar
  21. 21.
    Health Quality Ontario. Specialized nursing practice for chronic disease management in the primary care setting: an evidence-based analysis. Ont Health Technol Assess Ser. 2013;13(10):1–66.PubMedCentralGoogle Scholar
  22. 22.
    Halvorsen KH, Ruths S, Granas AG, et al. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care. 2010;28(2):82–8.CrossRefGoogle Scholar
  23. 23.
    Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100(4):428–37.CrossRefGoogle Scholar
  24. 24.
    Machado M, Bajcar J, Guzzo G, et al. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41(10):1569–82.CrossRefGoogle Scholar
  25. 25.
    Pelicano-Romano J, Neves MR, Amado A, et al. Do community pharmacists actively engage elderly patients in the dialogue? Results from pharmaceutical care consultations. Health Expect. 2013;18(5):1721–34.CrossRefGoogle Scholar
  26. 26.
    Machado M, Bajcar J, Guzzo GC, et al. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770–81.CrossRefGoogle Scholar
  27. 27.
    Machado M, Nassor N, Bajcar JM, et al. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother. 2008;42(9):1195–207.CrossRefGoogle Scholar
  28. 28.
    de Oliveira Santos D, Martins MC, Cipriano SL, et al. Pharmaceutical care for patients with persistent asthma: assessment of treatment compliance and use of inhaled medications. J Bras Pneumol. 2010;36(1):14–22.CrossRefGoogle Scholar
  29. 29.
    Stefanacci R, Riddle A. Preventing medication errors. Geriatr Nurs. 2016;37(4):307–10.CrossRefGoogle Scholar
  30. 30.
    Jutel A, Menkes DB. Nurses’ reported influence on the prescription and use of medication. Int Nurs Rev. 2010;57(1):92–7.CrossRefGoogle Scholar
  31. 31.
    Bajramovic J, Emmerton L, Tett SE. Perceptions around concordance: focus groups and semi-structured interviews conducted with consumers, pharmacists and general practitioners. Health Expect. 2004;7(3):221–34.CrossRefGoogle Scholar
  32. 32.
  33. 33.
    Population Composition: Regional population ageing. 2006.!OpenDocument. Accessed 15 Dec 2016.
  34. 34.
    Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.CrossRefGoogle Scholar
  35. 35.
    Data Saturation—numbers left out in the rain, or something else? 2018. Accessed 2 Mar 2018.
  36. 36.
    Phillippi J, Lauderdale J. A guide to field notes for qualitative research: context and conversation. Qual Health Res. 2018;28(3):381–8.CrossRefGoogle Scholar
  37. 37.
    Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRefGoogle Scholar
  38. 38.
    Nowell LS, Norris JM, White DE, et al. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16(1):1–13.CrossRefGoogle Scholar
  39. 39.
    Thomas DR. A general inductive approach for qualitative data analysis. Am J Eval. 2006;27(2):237–46.CrossRefGoogle Scholar
  40. 40.
    Cooper S, Endacott R. Generic qualitative research: a design for qualitative research in emergency care? Emerg Med J. 2007;24(12):816–9.CrossRefGoogle Scholar
  41. 41.
  42. 42.
    Lincoln YS, Guba EG. Naturalistic inquiry, vol. 75. Thousand Oaks: Sage Publishing; 1985.Google Scholar
  43. 43.
    Nik J, Lai PSM, Ng CJ, et al. A qualitative study of community pharmacists’ opinions on the provision of osteoporosis disease state management services in Malaysia. BMC Health Serv Res. 2016;16(1):448.CrossRefGoogle Scholar
  44. 44.
    Health Statistics and Information Systems—Definition of an older or elderly person. 2016. Accessed 20 Apr 2018.
  45. 45.
    Dubina TL, Dyundikova VA, Zhuk EV. Biological age and its estimation. II. Assessment of biological age of albino rats by multiple regression analysis. Exp Gerontol. 1983;18(1):5–18.CrossRefGoogle Scholar
  46. 46.
    Hochschild R. Improving the precision of biological age determinations. Part 1: a new approach to calculating biological age. Exp Gerontol. 1989;24(4):289–300.CrossRefGoogle Scholar
  47. 47.
    Zhang W-G, Zhu S-Y, Bai X-J, et al. Select aging biomarkers based on telomere length and chronological age to build a biological age equation. Age. 2014;36(3):9639.CrossRefGoogle Scholar
  48. 48.
    Klemera P, Doubal S. A new approach to the concept and computation of biological age. Mech Ageing Dev. 2006;127(3):240–8.CrossRefGoogle Scholar
  49. 49.
    Mutasingwa DR, Ge H, Upshur REG. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Phys. 2011;57(7):e253–62.Google Scholar
  50. 50.
    Cox L, Kloseck M, Crilly R, McWilliam C, et al. Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines. Can Fam Phys. 2011;57(7):e263–9.Google Scholar
  51. 51.
    Turazza FM, Franzosi MG. Is anticoagulation therapy underused in elderly patients with atrial fibrillation? Drugs Aging. 1997;10(3):174–84.CrossRefGoogle Scholar
  52. 52.
    Bajorek BV, Krass I, Ogle SJ, et al. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc. 2005;53(11):1912–20.CrossRefGoogle Scholar
  53. 53.
    Baunemann Ott CL, Ratna N, Prayag R, et al. Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba. Curr Oncol. 2011;18(5):e238–42.CrossRefGoogle Scholar
  54. 54.
    Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–51.CrossRefGoogle Scholar
  55. 55.
    Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093–104.CrossRefGoogle Scholar
  56. 56.
  57. 57.
    Ouchida K, Lachs M. Not for doctors only: ageism in healthcare. J Am Soc Ageing. 2015;39(3):46–57.Google Scholar
  58. 58.
    Bowling A. Ageism in cardiology. BMJ. 1999;319(7221):1353–5.CrossRefGoogle Scholar
  59. 59.
    Lavan AH, Gallagher PF, O’Mahony D. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging. 2016;11:857–66.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Leape LL, Cullen DJ, Dempsey Clapp M, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282(3):267–70.CrossRefGoogle Scholar
  61. 61.
    Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing: a randomized controlled trial. Med Care. 1992;30(7):646–58.CrossRefGoogle Scholar
  62. 62.
    Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother. 2009;43(6):1096–106.CrossRefGoogle Scholar
  63. 63.
    Marek K, Antle L. Medication management of the community-dwelling older adult. In: Hughes R, editor. Patient safety and quality: an evidence-based handbook for nurses. Rockville: Agency for Healthcare Research and Quality; 2008.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Graduate School of Health (Pharmacy)University of Technology SydneyBroadwayAustralia

Personalised recommendations